Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients Juan Caro-Codón, Juan R. Rey, Angel M. Iniesta, Sandra O. Rosillo, Sergio Castrejon-Castrejon, Laura Rodriguez-Sotelo, Jose M. Garcia-Veas, Irene Marco, Luis A. Martinez, Lorena Martin-Polo, Carlos Merino, Marcel Martinez-Cossiani, Antonio Buño, Luis Gonzalez-Valle, Alicia Herrero, Esteban López-de-Sá, Jose L. Merino

Hyperkalemia as a limiting factor of neurohormonal blockade/modulation in everyday clinical practice Henrique Vasconcelos, Joana Cabral, Emília Moreira, Manuel Campelo, Sandra Amorim, Brenda Moura, Alexandra Sousa, Roberto Pinto, Paulo Maia-Araújo, Cláudia Dias, José Silva-Cardoso

Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos